720 results on '"Scholl, Sebastian"'
Search Results
2. Validating genetic variants in innate immunity linked to infectious events in acute myeloid leukemia post-induction chemotherapy
3. Correction to: Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia
4. Targeting protein kinase C-α prolongs survival and restores liver function in sepsis: Evidence from preclinical models
5. Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia
6. Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
7. Effective bridging strategies prior to infusion with tisagenlecleucel results in high response rates and long-term remission in relapsed/refractory large B-cell lymphoma: findings from a German monocentric study
8. Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
9. Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia
10. Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
11. Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
12. Q-HAM: a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD
13. UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
14. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
15. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia
16. Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
17. Staphylococcus intermedius infection with splenic abscesses in a patient with acute lymphoblastic leukemia
18. Application of a nanoindentation-based approach for parameter identification to a crystal plasticity model for bcc metals
19. Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia
20. Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy
21. Significance of separations occurring in mechanical testing of thermomechanical rolled pipeline steels
22. Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma
23. Primär- und Rezidivtherapie akuter Leukämien
24. Ziele und Optionen der palliativen Therapie der akuten myeloischen Leukämie
25. Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia
26. Standardizing Nutritional Care for Cancer Patients: Implementation and Evaluation of a Malnutrition Risk Screening.
27. A comprehensive quantitative characterisation of the multiphase microstructure of a thick-section high strength steel
28. CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
29. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
30. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
31. A phase 1 single-arm, open-label study of emavusertib (CA-4948) in combination with azacitidine and venetoclax in patients (pts) with acute myeloid leukemia (AML) in complete response (CR) with measurable residual disease (MRD).
32. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
33. Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials
34. Numerical simulation of dual-phase steel based on real and virtual three-dimensional microstructures
35. Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
36. Synergistic Effects of the RARalpha Agonist Tamibarotene and the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Cells with KMT2A Rearrangement or NPM1 Mutation
37. Melphalan 200 mg/m2 does not increase toxicity and improves survival in comparison to reduced doses of melphalan in multiple myeloma patients
38. Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity
39. SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders
40. A 19-year-old patient with atypical chronic myeloid leukemia
41. HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient
42. No impact of time from diagnosis to treatment on survival in newly diagnosed AML treated with venetoclax-based regimens
43. Effective bridging strategies prior to infusion with tisagenlecleucel results in high response rates and long-term remission in relapsed / refractory large B-cell lymphoma: findings from a German monocentric study.
44. Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
45. Geographien des Protests
46. 5.3 Zwischenfazit: Raum, Protestkarawanen und die Führung der Protestkommunikation der MPJD
47. 6.2 Führungswirkungen der raumbezogenen Semantik der »nationalen Notlage«
48. Anhang
49. 6.1 Emergenz einer raumbezogenen Semantik der »nationalen Notlage« als Produkt sozialer Mobilisierung
50. 1.3 Forschungsdesiderat: Zur Frage nach der Relevanz von Raum im Spannungsfeld von aktiven und latenten Protestphasen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.